ARTICLE | Company News
Novia Pharmaceuticals, Quintiles deal
August 27, 2001 7:00 AM UTC
QTRN will provide preclinical testing services for Novia's AD4 antioxidant neuroprotectant to treat Parkinson's disease (PD) and other CNS indications. QTRN's PharmaBio Development group will take an ...